AbbVie looks set to recreate Humira patent thicketing success following Imbruvica victory
District of Delaware decision clears the way for the company to generate billions of dollars in sales well into the next decade
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.